The Radioactive Triolein Test in Malignant Disease
1961

Radioactive Triolein Test in Malignant Disease

Sample size: 34 publication Evidence: moderate

Author Information

Author(s): A. Centi Colella, W. S. Reith, E. S. Williams

Primary Institution: Institute of Nuclear Medicine, Middlesex Hospital Medical School

Hypothesis

How does malignant disease affect the results of the 131I-triolein fat absorption test?

Conclusion

The blood radioactivity was found to be lower in patients with malignant disease compared to normal subjects.

Supporting Evidence

  • The mean blood radioactivity was significantly lower in the malignant group compared to normal subjects.
  • Successful treatment improved blood radioactivity levels towards normal.
  • Statistical analysis showed significant differences in blood radioactivity between groups.

Takeaway

This study looked at how a special fat test works in people with cancer, finding that their blood showed less radioactivity than healthy people.

Methodology

Patients ingested a labelled fatty meal, and blood samples were taken at intervals to measure radioactivity.

Limitations

The technique used has limited utility and results should be interpreted with caution.

Participant Demographics

22 males and 12 females, aged 13-89 years.

Statistical Information

P-Value

p<0.001

Statistical Significance

p<0.001

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication